期刊
RHEUMATOLOGY INTERNATIONAL
卷 28, 期 7, 页码 631-635出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00296-007-0489-0
关键词
interleukin-6; inflammation; cannabinoid acid; macrophages; rheumatoid arthritis
类别
资金
- NIAID NIH HHS [AI1056362] Funding Source: Medline
- NIAMS NIH HHS [T32AR07572] Funding Source: Medline
- NIDA NIH HHS [DA3691] Funding Source: Medline
Interleukin-6 (IL-6) is a multifunctional cytokine which contributes to inflammation and tissue injury in several diseases. Thus, inhibition of IL-6 production may be a useful strategy for treatment of patients with diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). A synthetic nonpsychoactive cannabinoid, ajulemic acid (AjA), prevents joint damage in experimental arthritis. Results of experiments presented here indicate that addition of AjA (3-30 mu M) to human monocyte derived macrophages in vitro reduces steady state levels of IL-6 mRNA and the subsequent secretion of IL-6 from LPS stimulated cells. Although AjA binds to and activates PPAR gamma, its anti IL-6 effects are PPAR gamma independent. These studies provide evidence to support the view that AjA may prove to be an effective, safe antiinflammatory agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据